当前位置:首页 - 行情中心 - 东北制药(000597) - 财务分析 - 资产负债表

东北制药

(000597)

  

流通市值:65.96亿  总市值:68.60亿
流通股本:13.74亿   总股本:14.29亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金5,651,183,181.944,702,985,424.083,851,532,637.953,926,950,537.22
应收票据及应收账款2,397,220,604.742,724,323,537.982,799,576,254.032,760,653,584.12
其中:应收票据583,583,587.31593,404,976.45547,219,591.16557,318,385.15
应收账款1,813,637,017.432,130,918,561.532,252,356,662.872,203,335,198.97
预付款项150,056,969.6658,731,287.7983,655,937.38110,117,124.72
其他应收款合计191,253,188.85207,640,603.85206,864,427.5209,102,103.6
存货1,364,090,227.711,247,673,911.941,357,231,024.541,370,524,466.26
合同资产7,092,367.4610,605,095.984,450,697.374,475,022.29
其他流动资产22,163,503.6431,993,288.7833,180,859.3621,971,435.36
流动资产平衡项目0000
流动资产合计9,783,060,0448,983,953,150.48,336,491,838.138,403,794,273.57
非流动资产:
固定资产4,224,397,871.434,069,951,695.214,186,657,691.54,301,904,944.22
在建工程198,865,519.16414,584,742.84391,209,660.61391,857,875.75
使用权资产53,433,397.6458,130,804.7458,156,032.5457,639,946.97
无形资产681,773,700.33688,866,879.18702,173,439.99694,584,835.21
开发支出142,722,332.74140,160,076.56132,973,691.75145,439,767.53
商誉26,118,604.8126,118,604.8126,118,604.8126,118,604.81
长期待摊费用745,074.64814,460.83596,541.68641,985.77
递延所得税资产128,068,299.04118,805,103.76117,789,230.77103,723,263.26
其他非流动资产34,468,798.3439,196,415.6152,392,541.2860,420,618.05
非流动资产平衡项目0000
非流动资产合计5,490,593,598.135,556,628,783.545,668,067,434.935,782,331,841.57
资产平衡项目0000
资产总计15,273,653,642.1314,540,581,933.9414,004,559,273.0614,186,126,115.14
流动负债:
短期借款1,290,429,999.991,609,999,999.991,839,999,999.992,130,000,000
应付票据及应付账款5,777,647,320.024,864,011,643.694,678,278,194.134,342,767,783.62
其中:应付票据4,379,546,536.533,305,990,619.592,895,116,547.342,463,350,499.02
应付账款1,398,100,783.491,558,021,024.11,783,161,646.791,879,417,284.6
合同负债131,168,024.2996,798,766.92100,414,360.39146,527,064.17
应付职工薪酬53,553,942.122,264,561.082,412,108.2512,438,093.17
应交税费90,924,585.2174,746,714.7691,165,307.64146,022,094.69
其他应付款合计1,466,608,057.231,543,595,470.621,743,059,285.251,781,743,871.73
应付股利1,597,979.181,597,979.181,597,979.181,597,979.18
一年内到期的非流动负债746,721,625.2176,821,318.16176,432,978.4397,781,843.07
其他流动负债11,434,480.5810,594,216.098,793,019.7514,042,203.62
流动负债平衡项目0000
流动负债合计9,568,488,034.648,378,832,691.318,640,555,253.838,671,322,954.07
非流动负债:
长期借款150,000,000740,000,000140,000,000238,000,000
租赁负债31,287,024.2130,225,627.0630,892,032.932,268,886.41
递延收益157,118,947.05163,402,453.99167,697,624.5172,785,114.34
递延所得税负债5,217,346.265,287,981.135,287,981.135,287,981.13
其他非流动负债202,800,000220,400,000220,400,000238,000,000
非流动负债平衡项目0000
非流动负债合计546,423,317.521,159,316,062.18564,277,638.53686,341,981.88
负债平衡项目0000
负债合计10,114,911,352.169,538,148,753.499,204,832,892.369,357,664,935.95
所有者权益(或股东权益):
实收资本(或股本)1,429,103,2651,434,316,2651,434,316,2651,434,316,265
资本公积2,467,796,232.362,474,772,216.862,458,210,370.872,416,361,969.87
减:库存股110,717,740137,695,768234,779,188234,779,188
其他综合收益1,950,394.122,448,750.312,649,288.09838,342.19
专项储备6,455,322.56,486,882.946,497,303.156,407,903.15
盈余公积180,321,681.95172,911,034.42172,911,034.42172,911,034.42
未分配利润1,013,360,613.77881,524,255.84796,630,593.05875,226,134.55
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,988,269,769.74,834,763,637.374,636,435,666.584,671,282,461.18
少数股东权益170,472,520.27167,669,543.08163,290,714.12157,178,718.01
股东权益平衡项目0000
股东权益合计5,158,742,289.975,002,433,180.454,799,726,380.74,828,461,179.19
负债和股东权益合计15,273,653,642.1314,540,581,933.9414,004,559,273.0614,186,126,115.14
公告日期2024-03-302023-10-272023-08-232023-04-28
审计意见(境内)标准无保留意见
TOP↑